Featured Articles
 
Please Donate Blood!
During times like these, we must come together and help those in need.
Read more
 
 
Rimegepant Demonstrates Efficacy in Prevention of Migraine
Rimegepant (Nurtec ODT, Biohaven Pharmaceuticals) reduced monthly migraine days in patients with episode and chronic migraine in a clinical trial.
Read more
Read More
 
Clinical Trial Tests Efficacy of Short-Acting GLP-1 Receptor Agonist in Type 1 Diabetes
FDA Requests Removal of All Ranitidine from Market
Community Pharmacies Project Successful in Increasing Adult Vaccinations
RxSafe LLC Launches ViralGuardRx COVID-19 Protection